<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010091246">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Sibounheuang, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Boutthasavong, L.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chommanam, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Phommasone, K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Panapruksachat, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Praphasiri, V.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Bouttavong, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Sisavath, H.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Christy, N. C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Letizia, A. G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mayxay, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Vongsouvath, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ashley, E. A.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Dubot Pérès, Audrey</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Dry swabs and dried saliva as alternative samples for SARS-CoV-2 detection in remote areas in Lao PDR</title>
        <secondary-title>Open Forum Infectious Diseases</secondary-title>
      </titles>
      <pages>ofae433 [9 p.]</pages>
      <keywords>
        <keyword>COVID-19</keyword>
        <keyword>dry saliva spot</keyword>
        <keyword>dry swab</keyword>
        <keyword>resource-limited settings</keyword>
        <keyword>SARS-CoV-2</keyword>
        <keyword>LAOS</keyword>
      </keywords>
      <dates>
        <year>2024</year>
      </dates>
      <call-num>fdi:010091246</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Open Forum Infectious Diseases</full-title>
      </periodical>
      <isbn>2328-8957</isbn>
      <accession-num>ISI:001291225000001</accession-num>
      <number>8</number>
      <electronic-resource-num>10.1093/ofid/ofae433</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010091246</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-09/010091246.pdf</url>
        </pdf-urls>
      </urls>
      <volume>11</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Background Surveillance of SARS-CoV-2 circulation is mainly based on real-time reverse transcription-polymerase chain reaction, which requires laboratory facilities and cold chain for sample transportation. This is difficult to achieve in remote rural areas of resource-limited settings. The use of dried blood spots shipped at room temperature has shown good efficiency for the detection of arboviral RNA. Using a similar approach, we conducted a study at 3 provincial hospitals in Laos to compare the detection of SARS-CoV-2 from neat and dried spot samples.Methods Between January 2022 and March 2023, patients with respiratory symptoms were recruited. Nasopharyngeal/oropharyngeal swabs in virus transport medium (VTM), dry swabs, saliva, and dried saliva spotted on filter paper were collected. All samples were tested by SARS-CoV-2 real-time reverse transcription-polymerase chain reaction.Results In total, 479 participants were included. The VTM samples tested positive for 288 (60.1%). High positive percent agreements were observed for dry swab (84.8%; 95% CI, 80.2%-88.8%) and saliva (89.2%; 95% CI, 85.1%-92.6%) as compared with VTM. There was a loss of sensitivity when saliva was dried on filter paper (73.6%; 95% CI, 68.1%-78.6%) as compared with saliva. SARS-CoV-2 variant (Delta or Omicron) had no significant impact on the performance of the different sample types.Conclusions Our findings suggest that dry swabs could be a good alternative for sample collection and permit easy shipping at ambient temperature for subsequent viral SARS-CoV-2 RNA purification and molecular investigation. This is a useful tool to consider for a rapid implementation of large-scale surveillance of SARS-CoV-2 in remote areas, which could be extrapolated to other respiratory targets during routine surveillance or in the case of a novel emerging pandemic.</abstract>
      <custom6>052 ; 050</custom6>
      <custom1>UR190</custom1>
      <custom7>Laos</custom7>
    </record>
  </records>
</xml>
